These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10225692)

  • 1. Progress in cell therapy in Japan 1999.
    Takaue Y; Tanosaki R
    Jpn J Clin Oncol; 1999 Mar; 29(3):117-8. PubMed ID: 10225692
    [No Abstract]   [Full Text] [Related]  

  • 2. Dendritic cells and cancer: progress toward a new cellular therapy.
    Troy AJ; Hart DN
    J Hematother; 1997 Dec; 6(6):523-33. PubMed ID: 9483187
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?
    Auletta JJ; Devine SM; Waller EK
    Bone Marrow Transplant; 2016 Mar; 51(3):333-43. PubMed ID: 26642333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foreword. New frontiers in molecular and cellular therapy.
    Frassoni F; Locatelli F; Moretta L
    Immunol Lett; 2013; 155(1-2):1. PubMed ID: 24113356
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress on the treatment of tumors--present status and future of bonemarrow and peripheral hematopoietic stem cell transplantation].
    Takaue Y
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):347-50. PubMed ID: 8690992
    [No Abstract]   [Full Text] [Related]  

  • 6. Recruiting dendritic cells to improve antibody therapy of cancer.
    Dhodapkar KM; Dhodapkar MV
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6243-4. PubMed ID: 15851655
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation.
    Arpinati M; Chirumbolo G; Urbini B; Perrone G; Rondelli D; Anasetti C
    Transpl Immunol; 2003; 11(3-4):345-56. PubMed ID: 12967787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular therapies: a Canadian blood services research and development symposium.
    Shehata N; Lin Y; Pendergrast J; Branch DR
    Transfus Med Rev; 2007 Oct; 21(4):317-36. PubMed ID: 17900493
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological properties of dendritic cells: implications to their use in the treatment of cancer.
    van Schooten WC; Strang G; Palathumpat V
    Mol Med Today; 1997 Jun; 3(6):254-60. PubMed ID: 9211416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].
    Cheng YC; Ueno NT
    Nihon Rinsho; 2003 Sep; 61(9):1619-34. PubMed ID: 14515734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
    Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Therapies in Systemic Sclerosis: Recent Progress.
    van Rhijn-Brouwer FC; Gremmels H; Fledderus JO; Radstake TR; Verhaar MC; van Laar JM
    Curr Rheumatol Rep; 2016 Feb; 18(2):12. PubMed ID: 26943351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent molecular and cellular advances in pediatric bone marrow transplantation.
    Talano JA; Margolis DA
    Pediatr Clin North Am; 2006 Aug; 53(4):685-98. PubMed ID: 16872999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reconstitution kinetics of dendritic cells following allogeneic hematopoietic stem cell transplantation].
    Fu HX; Zhang XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):222-6. PubMed ID: 18315936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of immune reconstitution following hematopoietic stem cell transplantation.
    Peggs KS; Krauss AC; Mackall CL
    Cancer Treat Res; 2009; 144():131-54. PubMed ID: 19779871
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.
    Imamura M; Asano S; Harada M; Ikeda Y; Kato K; Kato S; Kawa K; Kojima S; Morishima Y; Morishita Y; Nakahata T; Okamura J; Okamoto S; Shiobara S; Tanimoto M; Tsuchida M; Atsuta Y; Yamamoto K; Tanaka J; Hamajima N; Kodera Y
    Int J Hematol; 2006 Feb; 83(2):164-78. PubMed ID: 16513537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of dendritic cells and their use in tumor therapy.
    Björck P
    Clin Immunol; 1999 Aug; 92(2):119-27. PubMed ID: 10444356
    [No Abstract]   [Full Text] [Related]  

  • 19. Harnessing dendritic cells to improve allogeneic hematopoietic cell transplantation outcome.
    Hashimoto D; Merad M
    Semin Immunol; 2011 Feb; 23(1):50-7. PubMed ID: 21316261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches].
    Mohty M; Gaugler B; Calmels B; Blaise D; Vey N; Chabannon C; Olive D
    Bull Cancer; 2003; 90(8-9):751-7. PubMed ID: 14609765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.